SCHEMBL600479

SCHEMBL600479

O=C(O)C=CSc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.68
LMNA P02545 6/20 0.68
MAPT P10636 6/20 0.68
NPSR1 Q6W5P4 4/20 0.68
PLIN1 O60240 2/20 0.68
PLIN5 Q00G26 2/20 0.68
ABHD5 Q8WTS1 2/20 0.68
HPGD P15428 2/20 0.68
HTT P42858 1/20 0.68
NFKB1 P19838 2/20 0.53
MEN1 O00255 1/20 0.53
NFKB2 Q00653 1/20 0.53
KMT2A Q03164 1/20 0.53
RELA Q04206 1/20 0.53
HCAR2 Q8TDS4 2/20 0.46
HDAC3 O15379 1/20 0.46
TNKS O95271 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9330897 1.00 ALDH1A1 (0.68) ALDH1A1LMNAMAPTNPSR1PLIN1
SCHEMBL600478 1.00 ALDH1A1 (0.68) ALDH1A1LMNAMAPTNPSR1PLIN1
Water SCHEMBL9776234 0.98 ALDH1A1 (0.66) ALDH1A1LMNAMAPTNPSR1PLIN1
Water SCHEMBL9776229 0.98 ALDH1A1 (0.66) ALDH1A1LMNAMAPTNPSR1PLIN1
Acetic Acid SCHEMBL28747365 0.94 ALDH1A1 (0.61) ALDH1A1LMNAMAPTNPSR1PLIN1
SCHEMBL7516062 0.83 ALDH1A1 (0.63) ALDH1A1LMNAMAPTNPSR1PLIN1
SCHEMBL7516071 0.83 ALDH1A1 (0.63) ALDH1A1LMNAMAPTNPSR1PLIN1
SCHEMBL4645504 0.83 ALDH1A1 (0.63) ALDH1A1LMNAMAPTNPSR1PLIN1
SCHEMBL13080235 0.83 ALDH1A1 (0.63) ALDH1A1LMNAMAPTNPSR1PLIN1
SCHEMBL9847361 0.81 ALDH1A1 (0.61) ALDH1A1LMNAMAPTNPSR1PLIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114921180-B Organic silicon modified epoxy resin gloss oil and preparation method thereof 广东绿色大地化工有限公司 2023-04-07 CN claimed
CN-114921180-A Organic silicon modified epoxy resin gloss oil and preparation method thereof 广东绿色大地化工有限公司 2022-08-19 CN claimed
CN-108219702-B Acrylic acid pressure-sensitive adhesive protection film 上海保立佳新材料有限公司 2020-11-27 CN claimed
US-7732625-B2 Colorant compounds XEROX CORPORATION (US) 2010-06-08 US claimed
US-7311767-B2 Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens XEROX CORPORATION (US) 2007-12-25 US claimed
US-7033424-B2 Phase change inks XEROX CORPORATION (US) 2006-04-25 US claimed
US-20060021546-A1 Processes for preparing phase change inks XEROX CORPORATION 2006-02-02 US claimed
US-20060020141-A1 Metallized dye XEROX CORPORATION 2006-01-26 US claimed
US-20060016369-A1 PHASE CHANGE INKS XEROX CORPORATION 2006-01-26 US claimed
US-6946025-B2 Process for preparing tetra-amide compounds XEROX CORPORATION (US) 2005-09-20 US claimed
US-6916890-B1 Thermally reworkable epoxy resins and compositions based thereon HENKEL CORPORATION (US) 2005-07-12 US claimed
US-20050090690-A1 Process for preparing tetra-amide compounds XEROX CORPORATION 2005-04-28 US claimed
WO-2003031492-A1 THERMALLY REWORKABLE EPOXY RESINS AND COMPOSITIONS BASED THEREO N HENKEL CORPORATION (US) 2003-04-17 WO claimed
CN-114921180-B Organic silicon modified epoxy resin gloss oil and preparation method thereof 广东绿色大地化工有限公司 2023-04-07 CN disclosed
CN-114921180-A Organic silicon modified epoxy resin gloss oil and preparation method thereof 广东绿色大地化工有限公司 2022-08-19 CN disclosed
CN-107001839-B Particles for electrophoretic displays 默克专利股份有限公司 2021-01-15 CN disclosed
EP-0408107-A2 Novel acrylic acid salts, a process for their preparation, pharmaceutical compositions containing them and their use in the medicine RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 1991-01-16 EP disclosed
US-4288364-A REACTING A 3-/2-HYDROXYIMINOACETYLAMINO/-2-OXOAZETIDINE WITH AN ORGANIC CARBONATE OR ACYL HALIDE CIBA-GEIGY CORPORATION (US) 1981-09-08 US disclosed
US-4198527-A Ether substituted cyclopropanecarboxylic acids and esters ZOECON CORPORATION (US) 1980-04-15 US disclosed
EP-0005507-A1 Process for the fragmentation of 3-(2-hydroxyimino-acetylamino)-2-oxo azetidin compounds and compounds obtained thereby CIBA-GEIGY AG (CH) 1979-11-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060020141-A1 Metallized dye CDYL, CDY1; CDY1B, CDYL2 ALDH1A1 1569/4885LMNA 1769/4885MAPT 4074/4885
US-20050090690-A1 Process for preparing tetra-amide compounds TAF9, TAF5, TAF1 ALDH1A1 1723/4885LMNA 2024/4885MAPT 539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.